☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Emergent BioSolutions
Emergent BioSolutions Entered into a Definitive Agreement with Chimerix to Acquire Tembexa (brincidofovir) Rights for Smallpox
May 16, 2022
Insights+: COVID-19 Healthcare News Monthly Updates - July 2020
July 31, 2020
AstraZeneca Signs an Agreement with Emergent BioSolutions to Expand Manufacturing of AZD1222 for COVID-19
July 28, 2020
Top COVID-19 Deals (Part II): Biopharma Vaccine Development
May 1, 2020
Insights+: COVID-19 Healthcare News Monthly Updates - August 2020
April 9, 2020
Emergent BioSolutions Announces Completion of Acquisition of PaxVax for ~$270M
October 5, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.